BTK and B-cell chronic lymphocytic leukemia: Besides the mutations of BTK and PCLγ2, studies with whole exome and deep-targeted sequencing studies have also described the clonal evolution of CLL developing resistance to BTK inhibition with expansion of clones with deletion of 8p and additional driver mutations of EP300, MLL2, EIF2A [61,66].